DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb Genomics, a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ...
DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, ...
New partnership brings transformative, high-resolution single-cell genomic technology to the field of preimplantation genetic testing in the pursuit of improved discovery and clinical outcomes. DURHAM ...
QIAGEN has released the QuantiTect® Whole Transcriptome Kit that delivers high and reproducible cDNA yields from limited amounts of RNA by whole transcriptome amplification (WTA). The cDNA is intended ...
RESEARCH TRIANGLE PARK – BioSkryb Genomics, a Durham developer of amplification tools for single-cell analysis, has signed an agreement with a Dutch company to expand distribution of BioSkryb’s ...
Applications that need accurate replication often require large amounts of high-quality DNA for analysis and archiving. Areas where high fidelity, low mutation whole genome amplification (WGA) is ...